CEP Clinical and Experimental PediatricsClin Exp Pediatr 2713-4148 Korean Pediatric Society 10.3345/cep.2026.err01 cep-2026-err01 Erratum: Authour correciton Author correction: Bifidobacterium animalis subsp. lactis BLa80 for preventing allergic, respiratory, and gastrointestinal diseases in young children in China: a randomized double-blind placebo-controlled trial ChenKe PhD 1 * ZhangXi MD 1 * ZengKaihong PhD 2 * ZhongJiayi MD 1 JinShanshan MD 1 NieYang BD 3 YangPing BD 4 HeNianyang BD 4 ChenHaixia BD 5 CaoYanmei BD 6 FuYunrong BD 7 FangZiji MD 8 JiangWei PhD 9 LiumChangqi PhD 10 Department of Clinical Nutrition, Chengdu Women’s & Children’s Central Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China Department of Health Management Center & Institute of Health Management, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu, China Department of Child Health Care, Chongzhou Maternal and Child Health Care Hospital, Chengdu, China Department of Child Health Care, Xindu Maternal and Child Health Care Hospital, Chengdu, China Baoxing Central for Disease Prevention and Control, Sichuan, China Department of Child Health Care, Dayi Maternal and Child Health Care Hospital, Sichuan, China Department of Child Health Care, Jinniu Maternal and Child Health Care Hospital, Sichuan, China School of Medicine, University of Electronic Science and Technology of China, Sichuan, China Laboratory of Microbiology, Immunology and Metabolism, Diprobio (Shanghai) Co., Limited, Shanghai, China School of Exercise and Nutritional Sciences, San Diego State University, San Diego, CA, USA

These authors contributed equally to this study as co-first authors.

 5 2026 28 4 2026 69 5 455 455 Copyright © 2026 by The Korean Pediatric Society 2026 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. <p>Clinical and Experimental Pediatrics 2026;69(2):150-162.</p> <p>Published online: October 30, 2025</p> <p>https://doi.org/10.3345/cep.2025.01256</p> </sec> <sec> <title/> <p>To the editor,</p> <p>Upon careful re-examination of the published article, we identified two inadvertent errors in the Results section of the Abstract. The original text incorrectly stated the direction of change for antimicrobial peptide levels between the intervention group (IG) and control group (CG).</p> <p>We sincerely apologize for this editorial oversight. This correction does not alter the primary conclusions of the study regarding the efficacy of <italic>Bifidobacterium animalis</italic> subsp. <italic>lactis</italic> BLa80 in preventing allergic, respiratory, and gastrointestinal diseases in young children.</p> <p>The two errors should be corrected as follows:</p> <sec> <title>1. First correction

Original (incorrect): "Postintervention, the IG had significantly lower concentrations of LL-37 ..."

Corrected: "Postintervention, the IG had significantly higher concentrations of LL-37..."

 2. Second correction

Original (incorrect): “Probiotic supplementation was also associated with a lower risk of URTIs (IG vs. CG: 40.3% vs. 20.7%; risk ratio [RR], 0.752; 95% confidence interval [CI], 0.653–0.866)…”

Corrected: “Probiotic supplementation was also associated with a lower risk of URTIs (CG vs. IG: 40.3% vs. 20.7%; risk ratio [RR], 0.752; 95% confidence interval [CI], 0.653–0.866)...”